Thalassemia Reports

Scope & Guideline

Connecting researchers to elevate thalassemia care.

Introduction

Explore the comprehensive scope of Thalassemia Reports through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Thalassemia Reports in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2039-4357
PublisherMDPI
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationTHALASS REP / Thalass. Rep.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND

Aims and Scopes

Thalassemia Reports focuses on advancing the understanding and management of thalassemia and related hemoglobin disorders through multidisciplinary research. The journal provides a platform for the latest findings in clinical practices, genetic studies, treatment innovations, and public health strategies. Here are the core areas of focus:
  1. Clinical Management of Thalassemia:
    Research addressing the clinical aspects of thalassemia treatment, including transfusion protocols, iron chelation therapy, and complications management.
  2. Genetic and Molecular Studies:
    Investigations into the genetic mutations associated with thalassemia, including epidemiological studies and gene therapy approaches.
  3. Psychosocial Impact of Thalassemia:
    Exploration of the psychological and social challenges faced by patients and families affected by thalassemia, emphasizing the importance of mental health in treatment adherence.
  4. Public Health and Screening Programs:
    Studies on the effectiveness of premarital screening and public health strategies for thalassemia prevention and management at community and national levels.
  5. Innovative Therapies and Treatment Advances:
    Research on new therapeutic approaches, including gene editing technologies like CRISPR, novel drug therapies, and their clinical implications for thalassemia patients.
Thalassemia Reports has shown a dynamic evolution in its research themes, with several emerging topics gaining traction in recent years. These trending areas highlight the journal's responsiveness to current challenges and advancements in the field. The following themes are increasingly prominent:
  1. Psychosocial Aspects and Quality of Life:
    There is a growing emphasis on understanding the psychosocial burden of thalassemia, particularly in pediatric populations, reflecting an awareness of the holistic care needs of patients.
  2. Gene Therapy and Genetic Engineering:
    Research focused on innovative gene therapies, including CRISPR technology and other genetic interventions, is increasingly prevalent as the field seeks curative strategies for thalassemia.
  3. Impact of COVID-19 on Thalassemia Management:
    Studies examining the implications of the COVID-19 pandemic on thalassemia patients, including treatment adherence and healthcare access, have risen sharply in response to global health challenges.
  4. Iron Overload Management Strategies:
    The exploration of new strategies for managing iron overload in thalassemia patients has gained importance, especially in the context of improving long-term health outcomes.
  5. Integration of Technology in Thalassemia Care:
    The incorporation of digital health technologies and telemedicine in managing thalassemia care is emerging as a significant trend, reflecting changes in healthcare delivery models.

Declining or Waning

While Thalassemia Reports has a diverse range of topics, certain themes appear to be declining in prominence based on recent publications. These waning areas may reflect shifting research priorities or completed cycles of investigation. The following themes have seen a reduction in focus:
  1. Historical Perspectives on Thalassemia:
    There has been a noticeable decrease in publications focusing on historical analyses or retrospective studies of thalassemia, possibly as the field shifts towards contemporary issues and innovations.
  2. Basic Science of Hemoglobinopathy:
    Research dedicated solely to the fundamental biological mechanisms of hemoglobinopathies, without clinical application, has become less frequent as the emphasis moves towards translational research.
  3. Global Epidemiology Studies:
    While still relevant, comprehensive global epidemiological studies on thalassemia prevalence have decreased, possibly due to increased focus on localized studies and specific populations.
  4. Comparative Studies of Treatment Modalities:
    The frequency of comparative studies evaluating various treatment modalities has waned, as the field may be converging on consensus therapies and practices.
  5. General Reviews without Novel Insights:
    General review articles that do not provide new insights or advancements in the field are less common, reflecting a trend towards more original research contributions.

Similar Journals

KLINISCHE PADIATRIE

Transforming Pediatric Care with Cutting-Edge Discoveries
Publisher: GEORG THIEME VERLAG KGISSN: 0300-8630Frequency: 6 issues/year

KLINISCHE PADIATRIE is a prominent academic journal published by GEORG THIEME VERLAG KG since its inception in 1972. Based in Germany, this journal serves as a valuable resource for professionals and researchers in the fields of Pediatrics, Perinatology, and Child Health. With an ISSN of 0300-8630 and E-ISSN 1439-3824, it features a rich array of peer-reviewed articles that focus on child health and development, encompassing clinical practices, therapeutic advances, and interdisciplinary approaches to pediatric care. While the journal operates on a subscription basis, its impact within the academic community is evidenced by its ranking of Q3 in Pediatrics, Perinatology, and Child Health as of 2023, and it maintains a solid standing within Q4 in Medicine (miscellaneous). The journal aims to bridge the gap between emerging research and clinical practice, providing a platform for innovative ideas that enhance pediatric care. Researchers, medical professionals, and students alike will find KLINISCHE PADIATRIE an essential addition to their academic repertoire, fostering advancements in pediatric healthcare and enriching knowledge in this vital field.

Journal of Hematology

Advancing the Frontiers of Blood Science
Publisher: ELMER PRESS INCISSN: 1927-1212Frequency: 4 issues/year

The Journal of Hematology, published by ELMER PRESS INC, serves as a pivotal platform for disseminating cutting-edge research in the field of hematology. With an ISSN of 1927-1212 and an E-ISSN of 1927-1220, this journal is committed to advancing scientific knowledge and clinical practice through high-quality peer-reviewed articles encompassing all aspects of blood disorders, from basic science to health policy implications. While the journal currently operates under a traditional access model, it nonetheless prioritizes the rapid publication of significant findings, ensuring that researchers, clinicians, and students have timely access to the latest advancements in hematological research. Positioned to bridge gaps in knowledge and foster collaboration among scholars worldwide, the Journal of Hematology is an essential resource for anyone invested in this vital area of medicine.

Oncology Research and Treatment

Empowering the future of oncology with cutting-edge insights.
Publisher: KARGERISSN: 2296-5270Frequency: 10 issues/year

Oncology Research and Treatment, published by KARGER, is a highly regarded academic journal dedicated to advancing the field of oncology through rigorous research and clinical insights. With a history spanning from 1978 to 1997 and continuing from 2013 to 2024, this journal provides a vital platform for researchers and professionals in cancer research, hematology, and related disciplines. Though currently listed in the Q3 tier of 2023 for Cancer Research, Hematology, and Oncology, its growing readership and open access policy enhance its visibility and impact within the scientific community. Based in Switzerland, the journal features diverse access options, reflecting the global importance of oncology research. With a focus on innovative treatments and the latest methodologies, Oncology Research and Treatment plays a crucial role in fostering collaboration and dialogue among researchers, professionals, and students alike, helping to shape the future of cancer care and management.

ANTIVIRAL THERAPY

Exploring innovative therapies for viral infections.
Publisher: SAGE PUBLICATIONS LTDISSN: 1359-6535Frequency: 8 issues/year

ANTIVIRAL THERAPY is a prominent academic journal dedicated to the field of infectious diseases and pharmacology, published by SAGE Publications Ltd in the United Kingdom. Since its inception in 1996, this journal has become an essential platform for disseminating cutting-edge research and innovative therapeutic approaches for viral infections, making significant contributions to advancements in medical science. With an HIndex indicating the quality and influence of its published work, ANTIVIRAL THERAPY holds prestigious rankings in its categories, including Q3 in Infectious Diseases and Pharmacology as of 2023. While it currently does not offer open access, the journal provides valuable insights that are crucial for researchers, healthcare professionals, and students engaged in antiviral research and treatment strategies. As it converges towards 2024, the journal continues to play a vital role in shaping the understanding and management of viral diseases, making it a critical resource for anyone involved in this important field of study.

AMERICAN JOURNAL OF HEMATOLOGY

Advancing Hematological Science Through Rigorous Research
Publisher: WILEYISSN: 0361-8609Frequency: 12 issues/year

American Journal of Hematology, published by Wiley, stands as a premier outlet for the dissemination of cutting-edge research in the field of hematology. With a commendable impact factor and ranked #9 out of 137 in the Scopus medicine category, this journal has established a robust presence since its inception in 1976. Operating in the Q1 quartile for hematology, it serves as a crucial resource for researchers, clinicians, and students dedicated to understanding blood disorders and advancing treatment methodologies. While the journal does not currently offer open access options, it remains highly regarded for its rigorous peer-review process and impactful contributions to the scientific community. With coverage extending into 2024, the American Journal of Hematology is committed to fostering innovation and collaboration within the hematological sciences.

Journal of Diabetology

Championing open access to diabetes knowledge.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2543-3288Frequency: 3 issues/year

The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.

TRANSFUSION MEDICINE AND HEMOTHERAPY

Advancing transfusion science for better patient outcomes.
Publisher: KARGERISSN: 1660-3796Frequency: 6 issues/year

TRANSFUSION MEDICINE AND HEMOTHERAPY, published by KARGER, is a prominent journal dedicated to advancing the fields of hematology and transfusion medicine. With an ISSN of 1660-3796 and E-ISSN 1660-3818, this esteemed journal has been a valuable resource for researchers and clinicians since its inception in 1973, with significant publication phases continuing into 2024. It currently holds a Q2 ranking in Hematology and a Q3 ranking in Immunology and Allergy, reflecting its impact and relevance in these critical fields. The journal features original articles, reviews, and clinical studies, presenting cutting-edge research that aids in the development of effective therapies and enhances patient care. Open access options are available, ensuring that crucial findings are accessible to a broad audience. As an important platform for dialogue and advancement in transfusion science, TRANSFUSION MEDICINE AND HEMOTHERAPY supports the global health community's efforts to improve treatment outcomes and foster innovation in medical practices.

Journal of Pain Research

Pioneering Discoveries in Pain Science
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7090Frequency: 1 issue/year

Journal of Pain Research, published by DOVE MEDICAL PRESS LTD, stands at the forefront of the field of pain management and anesthesia, offering a critical platform for researchers and clinicians dedicated to advancing the understanding of pain and its treatment. With an Open Access model since 2008, this journal enhances accessibility to high-quality research, enabling a global audience to engage with innovative studies and findings. Recognized for its significant contributions, it has achieved a Q2 rank in Anesthesiology and Pain Medicine as of 2023, placing it among the top 30% in its category, and it holds a commendable Scopus rank of 41/136 in its field. Covering a broad scope encompassing clinical trials, pharmacology, and psychosocial aspects of pain, the journal invites submissions that advance both theoretical knowledge and practical applications, making it an invaluable resource for professionals, researchers, and students aiming to improve outcomes in pain management.

INDIAN JOURNAL OF CANCER

Empowering Cancer Research, Inspiring Change
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0019-509XFrequency: 4 issues/year

INDIAN JOURNAL OF CANCER, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of oncology, providing dedicated insight into cancer research and its clinical applications since its inception in 1965. With an ISSN of 0019-509X and an E-ISSN of 1998-4774, this esteemed journal facilitates the dissemination of knowledge related to cancer prevention, diagnosis, and treatment strategies within the Indian context and beyond. Although classified within the Q3 quartile of oncology journals and ranked #292 out of 404 in its category in the Scopus database, the INDIAN JOURNAL OF CANCER continues to play a vital role in advancing the dialogue around cancer management. This journal is particularly significant for researchers, professionals, and students intent on contributing to the evolving landscape of oncology, offering a platform for sharing innovative findings and fostering collaboration among the academic community. Located in Mumbai, India, the journal's commitment to impactful research is reflected in its ongoing efforts to bridge gaps in cancer knowledge and address the unique challenges faced within the region and globally.

Journal of Blood Medicine

Unlocking Potential: Transforming Knowledge into Practice in Blood Medicine
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-2736Frequency: 1 issue/year

The Journal of Blood Medicine, published by DOVE MEDICAL PRESS LTD, stands as a vital resource in the field of hematology, focusing on the latest research developments and clinical advancements in blood medicine. With an impact factor reflective of its growing relevance, this open-access journal has been delivering quality scholarly work since 2010, ensuring that critical research is readily available to the global scientific community. The journal operates under an open-access model, further enhancing its dissemination and accessibility to researchers, professionals, and students alike. In the 2023 rankings, it secured a Q3 category status within hematology and achieved a commendable 76th rank out of 137 in Scopus listings, indicating its commitment to quality and innovation in this specialized area. Located in New Zealand, the journal's diverse topics encompass clinical research, treatment modalities, and emerging therapies, contributing significant insights vital for shaping future advancements in blood medicine.